-- MGXリソーシズ（ASX:MGX）とタナミ・ゴールド（ASX:TAM）がそれぞれ50%の権益を保有するセントラル・タナミ・プロジェクト合弁事業は、ノーザンテリトリーのグラウンドラッシュ金鉱床における探査坑道の建設工事の優先請負業者として、マクマホン・ホールディングス（ASX:MAH）傘下の企業を選定した。これは、火曜日にオーストラリア証券取引所に提出された個別の書類で明らかになった。 マクマホン・アンダーグラウンドは、約3,500メートルの探査坑道の掘削、坑口および通気口の設置工事を実施する予定で、工事費は約3,800万豪ドルとなる。工事は9月期に開始され、14ヶ月間続く見込み。 マクマホンの選定は、拘束力のある契約の最終締結を条件とする。
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF